Rachel Horn advises clients on a broad range of corporate and transactional matters, including corporate formation and governance, mergers and acquisitions, public and private offerings, and SEC reporting and compliance. Ms. Horn also frequently represents and advises biotechnology and pharmaceutical companies in negotiating agreements for the research, development, and commercialization of intellectual property and technology, including license and collaboration arrangements, clinical trial agreements, and manufacturing and supply arrangements.


  • JD, Georgetown University Law Center, 2013, cum laude
  • BA, Brandeis University, 2009, magna cum laude
  • District of Columbia
  • Delaware

Email Disclaimer